SCHEMBL21089461

SCHEMBL21089461

Oc1ccccc1-c1nc2c(-c3cccc4c3oc3ccccc34)cc(-c3cccc4c3oc3ccccc34)cc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
GGPS1 O95749 1/20 0.37
PTGES2 Q9H7Z7 1/20 0.37
MAPT P10636 3/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
PRKDC P78527 4/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
MAOA P21397 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TOP2A P11388 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21089269 0.95 ALOX5 (0.46) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089316 0.95 ALOX5 (0.47) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089197 0.94 ALOX5 (0.48) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089399 0.92 ALOX5 (0.45) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089211 0.90 ALOX5 (0.47) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089493 0.90 ALOX5 (0.45) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089314 0.90 ALOX5 (0.41) ALOX5MAPTHPGDSMN1; SMN2PRKDC
SCHEMBL21089198 0.89 ALOX5 (0.48) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089407 0.88 ALOX5 (0.43) ALOX5GGPS1PTGES2MAPTHPGD
SCHEMBL21089207 0.87 ALOX5 (0.42) ALOX5GGPS1PTGES2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-31 US disclosed
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LAPTO CO., LTD. (KR) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device CHRM1, L1CAM, CHRM4 ALOX5 4229/4885GGPS1 3769/4885PTGES2 4626/4885
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, L1CAM, CHRM4 ALOX5 4229/4885GGPS1 3769/4885PTGES2 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.